Israeli researchers have developed an artificial intelligence technology that can analyze ECG data and forecast heart failure with an unheard-of level of precision.
According to the Times of Israel, the device is now being utilized for patients with myositis, a disorder that dramatically raises the risk of heart failure.
Data from ECG scans and medical records of 89 patients with myositis between 2000 and 2020 were fed into the AI model to upgrade it. According to the findings, AI can recognize tiny ECG irregularities and foresee potential cardiac failure far in advance.
The tool’s chief researcher, Dr. Shahar Shelly of Rambam Healthcare Campus, told the Times of Israel that it was the first artificial intelligence (AI) specifically designed for patients.
“We are running ECG tests through the AI model. Which sees details that doctors can’t normally detect and then predicts who is at risk of heart failure,” said Shelly.
“Given that it’s these cardiac dysfunctions that often end up killing people, this can save lives.”
Researchers from the famed Mayo Clinic Medical Center in the United States and Shelly and his team collaborated on the study.
“Further down the road, the use of this model will allow the provision of appropriate treatments at an early stage. Even before the deterioration of the patient’s medical condition,” he said.
“We are talking here about preventing serious illness and even deaths.”
